TY - JOUR
T1 - Acute reduction of neuronal RNA binding Elavl2 protein and Gap43 mRNA in mouse hippocampus after kainic acid treatment
AU - Ohtsuka, Takafumi
AU - Yano, Masato
AU - Okano, Hideyuki
N1 - Funding Information:
We are grateful to Dr. Robert B. Darnell for a kind gift of anti-sera against Pan-nElavl, to all the members of Okano laboratory, particularly I. Koya and S. Suyama for technical advice and helpful discussions and Y. Hayakawa-Yano for critical comments. This work was supported by grants from the SIL Research Fund from the Takeda Pharmaceutical Company, Ltd. (to M. Y and H. O, J14K0123 ), and a Grant-in-Aid for Encouragement of Young Medical Scientists and the Keio University Doctorate Student Grant-in-Aid Program from Keio University and the Japan Society for the Promotion of Science (to T. O, 05-045-0233 ).
Publisher Copyright:
© 2015 Elsevier Inc.
Copyright:
Copyright 2016 Elsevier B.V., All rights reserved.
PY - 2015/8/24
Y1 - 2015/8/24
N2 - Activity-dependent gene regulation in neurons has been hypothesized to be under transcriptional control and to include dramatic increases in immediate early genes (IEGs) after neuronal activity. In addition, several reports have focused on post-transcriptional regulation, which could be mediated by neuronal post-transcriptional regulators, including RNA binding proteins (RNABPs). One such protein family is the neuronal Elavls (nElavls; Elavl2, Elavl3, and Elavl4), whose members are widely expressed in peripheral and central nervous system. Previous reports showed that Elavl3 and 4 are up-regulated following repeated stimulation such as during cocaine administration, a seizure, or a spatial discrimination task. In this study, we focused on Elavl2, a candidate gene for schizophrenia and studied its role in neuronal activity. First we found that Elavl2 has a cell-type specific expression pattern that is highly expressed in hippocampal CA3 pyramidal neurons and hilar interneurons using Elavl2 specific antibody. Second, unexpectedly, we discovered that the Elavl2 protein level in the hippocampus was acutely down-regulated for 3 h after a kainic acid (KA)-induced seizure in the hippocampal CA3 region. In addition, level of Gap43 mRNA, a target mRNA of Elavl2 is decreased 12 h after KA treatment, thus suggesting the involvement of Elavl2 in activity-dependent RNA regulation.
AB - Activity-dependent gene regulation in neurons has been hypothesized to be under transcriptional control and to include dramatic increases in immediate early genes (IEGs) after neuronal activity. In addition, several reports have focused on post-transcriptional regulation, which could be mediated by neuronal post-transcriptional regulators, including RNA binding proteins (RNABPs). One such protein family is the neuronal Elavls (nElavls; Elavl2, Elavl3, and Elavl4), whose members are widely expressed in peripheral and central nervous system. Previous reports showed that Elavl3 and 4 are up-regulated following repeated stimulation such as during cocaine administration, a seizure, or a spatial discrimination task. In this study, we focused on Elavl2, a candidate gene for schizophrenia and studied its role in neuronal activity. First we found that Elavl2 has a cell-type specific expression pattern that is highly expressed in hippocampal CA3 pyramidal neurons and hilar interneurons using Elavl2 specific antibody. Second, unexpectedly, we discovered that the Elavl2 protein level in the hippocampus was acutely down-regulated for 3 h after a kainic acid (KA)-induced seizure in the hippocampal CA3 region. In addition, level of Gap43 mRNA, a target mRNA of Elavl2 is decreased 12 h after KA treatment, thus suggesting the involvement of Elavl2 in activity-dependent RNA regulation.
KW - Elavl2
KW - Neuronal activity
KW - Post-transcriptional control
KW - RNA binding protein
UR - http://www.scopus.com/inward/record.url?scp=84941943527&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84941943527&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2015.08.103
DO - 10.1016/j.bbrc.2015.08.103
M3 - Article
C2 - 26325429
AN - SCOPUS:84941943527
SN - 0006-291X
VL - 466
SP - 46
EP - 51
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 1
M1 - 34476
ER -